A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 21, Pages 4930
Publisher
MDPI AG
Online
2020-10-26
DOI
10.3390/molecules25214930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation
- (2020) James M. Nichols et al. Journal of Neuroimmune Pharmacology
- The Cuprizone Model: Dos and Do Nots
- (2020) Jiangshan Zhan et al. Cells
- Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors
- (2020) Yi Yang et al. MOLECULES
- Phytocannabinoids: Origins and Biosynthesis
- (2020) Thies Gülck et al. TRENDS IN PLANT SCIENCE
- Conversion of cannabidiol (CBD) to Δ9-tetrahydrocannabinol (Δ9-THC) during protein precipitations prior to plasma samples analysis by chromatography – Troubles with reliable CBD quantitation when acidic precipitation agents are applied
- (2020) Michal P. Dybowski et al. TALANTA
- Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update
- (2019) Ingo Gerhauser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
- (2019) Raquel Guerrero-Alba et al. Frontiers in Pharmacology
- Complete biosynthesis of cannabinoids and their unnatural analogues in yeast
- (2019) Xiaozhou Luo et al. NATURE
- Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol
- (2019) Samuel D. Banister et al. ACS Chemical Neuroscience
- Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis
- (2019) Anthony Feinstein et al. BRAIN
- Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
- (2019) Zinah Z. Al-Ghezi et al. BRAIN BEHAVIOR AND IMMUNITY
- Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis
- (2019) Ting Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Immunology
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Cannabinoids for Treatment of MS Symptoms: State of the Evidence
- (2018) Jessica Rice et al. Current Neurology and Neuroscience Reports
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Biochemically altered myelin triggers autoimmune demyelination
- (2018) Andrew V. Caprariello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
- (2018) Andrea Manterola et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic applications of cannabinoids
- (2018) Nancy Maurya et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inhibitory effects of cannabidiol on voltage-dependent sodium currents
- (2018) Mohammad-Reza Ghovanloo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (2018) Natascia Bruni et al. MOLECULES
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
- (2017) Sebastian Schimrigk et al. EUROPEAN NEUROLOGY
- Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis
- (2017) Coral González-García et al. EXPERIMENTAL NEUROLOGY
- Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
- (2017) John-Mark K. Fitzpatrick et al. NEUROPHARMACOLOGY
- Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis
- (2017) Guido van Amerongen et al. CLINICAL THERAPEUTICS
- Evaluating Sativex®in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis
- (2016) Margherita Russo et al. PAIN MEDICINE
- Medicinal chemistry of cannabinoids
- (2015) V Kiran Vemuri et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
- (2015) Letizia Leocani et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study
- (2015) Laura Ferrè et al. NEUROLOGICAL SCIENCES
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
- (2015) A. Rahimi et al. NEUROSCIENCE
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis, cannabis, and cognition: A structural MRI study
- (2015) Kristoffer Romero et al. NeuroImage-Clinical
- Revised diagnostic criteria of multiple sclerosis
- (2014) Ron Milo et al. AUTOIMMUNITY REVIEWS
- Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
- (2014) S. Vlachou et al. CURRENT PHARMACEUTICAL DESIGN
- Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity
- (2014) Jürgen Koehler et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Effects of cannabis on cognition in patients with MS: A psychometric and MRI study
- (2014) B. Pavisian et al. NEUROLOGY
- Immunomodulatory activity of interferon-beta
- (2014) Lloyd H. Kasper et al. Annals of Clinical and Translational Neurology
- Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future
- (2014) George Panagis et al. Frontiers in Psychiatry
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- Extent of illicit drug use and dependence, and their contribution to the global burden of disease
- (2012) Louisa Degenhardt et al. LANCET
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- (2012) R. G. Pertwee PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids: Occurrence and Medicinal Chemistry
- (2011) G. Appendino et al. CURRENT MEDICINAL CHEMISTRY
- Effects of cannabis on cognitive function in patients with multiple sclerosis
- (2011) K. Honarmand et al. NEUROLOGY
- The impact of early-onset cannabis use on functional brain correlates of working memory
- (2010) Benjamin Becker et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The cuprizone animal model: new insights into an old story
- (2009) Markus Kipp et al. ACTA NEUROPATHOLOGICA
- An introduction to the endocannabinoid system: from the early to the latest concepts
- (2009) Luciano De Petrocellis et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis
- (2008) Massimiliano Aragona et al. CLINICAL NEUROPHARMACOLOGY
- Acute hemorrhagic demyelination in a murine model of multiple sclerosis
- (2008) Istvan Pirko et al. Journal of Neuroinflammation
- Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8
- (2008) L. De Petrocellis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started